Gilead Hit With Suit In HIV Drug Patent Manipulation Row
AIDS Healthcare Foundation Inc. on Tuesday filed a California federal suit seeking to invalidate patents for Gilead Sciences Inc.'s HIV/AIDS prevention drug Genvoya and also accused the company of blocking affordable...To view the full article, register now.
Already a subscriber? Click here to view full article